Business / Finance

RSS

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and twelve months ended December 31, 2013.

4 Mar 2014

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering.

4 Mar 2014

OPKO Health consolidated revenues increase about 30% to $20.7 million in Q4 2013

OPKO Health, Inc., a multi-national biopharmaceutical and diagnostics company, today reported operating and financial results for its 2013 fourth quarter and full year ended December 31, 2013.

4 Mar 2014

TeamHealth announces merger with Salutis Emergency Specialists operations

TeamHealth Holdings, one of the nation's largest providers of outsourced physician staffing solutions for hospitals, announced a merger with the operations of Salutis Emergency Specialists, PLLC. Based in Martinsburg, W. Va., Salutis Emergency Specialists manages and staffs the hospital emergency department for University Healthcare, Berkeley Medical Center (formerly City Hospital), which provides emergency care for approximately 54,000 patients annually.

4 Mar 2014

Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013.

From Mindray 4 Mar 2014

Universal Health Services acquires Palo Verde from Tucson Medical Center

Universal Health Services, Inc. announced today that it has completed the acquisition of Palo Verde Behavioral Health from Tucson Medical Center. Palo Verde currently operates 48 adult inpatient psychiatric beds. This acquisition establishes the Company's presence in the Tucson market and expands UHS's behavioral health presence in Arizona which includes Valley Hospital, an acute inpatient psychiatric hospital and Calvary Addiction Recovery Center, both located in Phoenix.

4 Mar 2014

forMD launches private online community for alumni of Hospital for Special Surgery

forMD, an innovative provider of specialty physician communities, has launched a private online community for alumni of Hospital for Special Surgery (HSS), one of the nation's leading orthopedic hospitals.

4 Mar 2014

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

TherapeuticsMD, Inc., a women's healthcare company, today announced results for the three-month period and full-year ended December 31, 2013.

4 Mar 2014

Wilson Medical Center, Duke LifePoint Healthcare complete formation of new joint venture

Wilson Medical Center and Duke LifePoint Healthcare have completed the formation of their new joint venture following approval by the Attorney General of North Carolina. The organizations now officially share ownership and operation of Wilson Medical Center.

3 Mar 2014

Tyco signs definitive agreement to sell South Korean security business to The Carlyle Group

Tyco today announced that it has signed a definitive agreement to sell Tyco Fire & Security Services Korea Co. Ltd. and its subsidiaries (ADT Caps Co., Ltd., Capstec Co., Ltd. and ADT Security Co., Ltd.) that form and operate the Company's South Korean security business ("ADT Korea") to The Carlyle Group, in a cash transaction valued at approximately $1.93 billion.

3 Mar 2014

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year-ended December 31, 2013.

3 Mar 2014

Magellan Health Services reports net revenue of $3.5 billion for fourth quarter 2013

Magellan Health Services, Inc. today reported financial results for the fourth quarter and full year 2013, as summarized below.

3 Mar 2014

Roark Capital Group invests in Anytime Fitness

Anytime Fitness, the world's largest and fastest-growing co-ed fitness franchise, today announced that an affiliate of Roark Capital Group, an Atlanta-based private equity firm that focuses on investing in the franchise industry, has made an equity investment in the company.

3 Mar 2014

RainDance Technologies closes $16.5 million Series E financing round

RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing.

3 Mar 2014

Aetna announces quarterly cash dividend, sanctions additional repurchase of common stock

The Board of Directors of Aetna declared a quarterly cash dividend of $0.225 per share on the company's common stock.

3 Mar 2014

Astellas Pharma to exclusively commercialize isavuconazole in the U.S. and Canada

Astellas Pharma Inc. announced today that the company has amended the License, Co-Development and Co-Promotion Agreement on isavuconazole under co-development with Basilea Pharmaceutica Ltd.

28 Feb 2014

Dyax reports total revenues of $16.9 million for fourth quarter 2013

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2013.

28 Feb 2014

HMS Holdings' fourth quarter revenue decreases 8.6% to $121.6 million

HMS Holdings Corp. today announced financial and operating results for the fourth quarter and full year ended December 31, 2013.

28 Feb 2014

Perrigo Company acquires basket of value-brand OTC products in Australia

Perrigo Company plc announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash.

28 Feb 2014

Abingworth announces final closing of £225M ($375M) fund

Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the final closing of its £225m ($375m) fund, Abingworth Bioventures VI (ABV VI). ABV VI, Abingworth's 10th life sciences fund, exceeded its target of £200 million and invests in life sciences and healthcare both in Europe and the US.

28 Feb 2014

Business / Finance

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

OPKO Health consolidated revenues increase about 30% to $20.7 million in Q4 2013

TeamHealth announces merger with Salutis Emergency Specialists operations

Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

Universal Health Services acquires Palo Verde from Tucson Medical Center

forMD launches private online community for alumni of Hospital for Special Surgery

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

Wilson Medical Center, Duke LifePoint Healthcare complete formation of new joint venture

Tyco signs definitive agreement to sell South Korean security business to The Carlyle Group

Akorn's consolidated revenue for fourth quarter 2013 increases 19% to $85 million

Magellan Health Services reports net revenue of $3.5 billion for fourth quarter 2013

Roark Capital Group invests in Anytime Fitness

RainDance Technologies closes $16.5 million Series E financing round

Aetna announces quarterly cash dividend, sanctions additional repurchase of common stock

Astellas Pharma to exclusively commercialize isavuconazole in the U.S. and Canada

Dyax reports total revenues of $16.9 million for fourth quarter 2013

HMS Holdings' fourth quarter revenue decreases 8.6% to $121.6 million

Perrigo Company acquires basket of value-brand OTC products in Australia

Abingworth announces final closing of £225M ($375M) fund

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News